The NP contacts SM to discuss the imaging results. SM is delighted that the results show no sign of cancer, and reports that her breast pain has been better since her last visit. SM has not taken any OTC NSAID products and has not yet shopped for a new bra. The NP discusses two options for further follow-up: a repeat left breast USG in 6 months or a USG-guided biopsy of the left breast mass in 2-4 weeks to verify that it is benign. The NP further explains that if the biopsy results confirm that the mass is a fibroadenoma, no excision is necessary. The plan would still be to repeat the USG in 6 months to check for stability as per American College of Surgeons guidelines. 16
The original brand name of oxandrolone was Anavar, which was marketed in the United States and the Netherlands .   This product was eventually discontinued and replaced in the United States with a new product named Oxandrin, which is the sole remaining brand name for oxandrolone in the United States.   Oxandrolone has also been sold under the brand names Antitriol ( Spain ), Anatrophill ( France ), Lipidex ( Brazil ), Lonavar ( Argentina , Australia , Italy ), Protivar, and Vasorome ( Japan ) among others.     Additional brand names exist for products that are manufactured for the steroid black market.